Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. (Q40459361)
Jump to navigation
Jump to search
scientific article published on 21 December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. |
scientific article published on 21 December 2004 |
Statements
1 reference
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. (English)
1 reference
Dirk Strumberg
1 reference
Heike Richly
1 reference
Ralf A Hilger
1 reference
Norbert Schleucher
1 reference
Sonke Korfee
1 reference
Mitra Tewes
1 reference
Markus Faghih
1 reference
Erich Brendel
1 reference
Dimitris Voliotis
1 reference
Claus G Haase
1 reference
Brian Schwartz
1 reference
Ahmad Awada
1 reference
Rudolf Voigtmann
1 reference
Max E Scheulen
1 reference
Siegfried Seeber
1 reference
21 December 2004
1 reference
1 reference
Identifiers
1 reference